China is home to one of the largest pharmaceutical markets in the world offering access to vast patient populations with an increasingly westernized incidence of disease. For manufacturers of pharmaceuticals, biologics and certain medical devices looking to enter China, the China Food and Drug Administration (CFDA) requires the conduct of clinical trials to support market applications. In addition, China is also becoming an increasingly more attractive location to support Regional and Global product development. With the CFDA making a conscious effort to improve the regulatory environment as well as industry quality standards in general, China has seen a large influx of clinical studies from Sponsors all over the world spanning all kinds of Therapeutic Areas.
The opportunities for drug and device manufacturers in China are matched only by the challenges that are also unique to China. That’s why it’s of growing importance to work with a CRO that is local to the area, that understands how to navigate through the obstacles and take full advantage of the opportunities.
You need to find a CRO that can:
In order to do so in China your partner must:
This is who we are, this is what we do.
If you would like to learn more about R&G, please download our brochure or feel free to contact us directly.